Fate Therapeutics is a clinical-stage biopharmaceutical and biotechnology company dedicated to the development of first-in-class cellular immunotherapies. The company pioneers an approach centered on cell programming, utilizing human induced pluripotent stem cells (iPSCs) to engineer standardized, off-the-shelf multiplexed cellular products, including natural killer cells and T cells designed for cancer immunotherapy and autoimmune disease treatments.